Patent ID: 9464044
Filing Date: 2016-10-11
CPC Classification: A61P,C07C,C07D

Claim Text:
1. A compound or pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of the following compounds: (3) E-4-[1-((2-fluoro-benzenesulfonylamino)methyl)cyclopropanecarboxamido]-adamantan-1-carboxylic acid amide; (22) E-4-[1-((2-fluoro-N-methyl-benzenesulfonylamino)methyl)cyclopropanecarboxamido]-adamantan-1-carboxylic acid amide; (71) E-4-[2-(2-fluoro-benzenesulfonylamino)-2-methylpropanamido]-adamantan-1-carboxylic acid amide; (84) E-4-[2-(2,6-difluoro-benzenesulfonylamino)-2-methylpropanamido]adamantan-1-carboxylic acid amide; (113) E-sodium[3-((5-carbamoyladamantan-2-yl)carbamoyl)phenyl]-2-fluoro-3-chloro-benzenesulfonylamide; and (119) E-4-[3-(3,5-dichloro-benzenesulfonylamino)-benzamido]-adamantan-1-carboxylic acid amide.